Which statement describes second-line migraine prophylaxis?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

Which statement describes second-line migraine prophylaxis?

Explanation:
Second-line migraine prophylaxis refers to meds used after first-line options are inadequate or not tolerated. Antidepressants, particularly tricyclics like amitriptyline, help prevent migraines by modulating central pain pathways through serotonin and norepinephrine systems and can also improve sleep, a common trigger factor. Antipsychotics have been used in refractory cases because their dopamine and serotonin antagonism can reduce central sensitization and help with associated symptoms, though they carry more side effects and are not preferred as first-line due to risk-benefit concerns. In contrast, NSAIDs and triptans treat acute attacks, not prevention, and first-line prophylaxis typically includes agents like beta-blockers or anticonvulsants. So, antidepressants and antipsychotics describe second-line prophylaxis.

Second-line migraine prophylaxis refers to meds used after first-line options are inadequate or not tolerated. Antidepressants, particularly tricyclics like amitriptyline, help prevent migraines by modulating central pain pathways through serotonin and norepinephrine systems and can also improve sleep, a common trigger factor. Antipsychotics have been used in refractory cases because their dopamine and serotonin antagonism can reduce central sensitization and help with associated symptoms, though they carry more side effects and are not preferred as first-line due to risk-benefit concerns. In contrast, NSAIDs and triptans treat acute attacks, not prevention, and first-line prophylaxis typically includes agents like beta-blockers or anticonvulsants. So, antidepressants and antipsychotics describe second-line prophylaxis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy